Foundation Medicine, part of Roche, plans to acquire Morrisville-based SAGA Diagnostics for up to $595 million. The deal centers on SAGA’s Pathlight blood test for cancer detection and monitoring, with the companies aiming to close in the third quarter and expand the platform’s reach globally.